The Series A-2 Preferred Stock was previously issued under a Purchase Agreement dated December 15, 2023, involving the Company and its largest shareholders, who collectively appointed half of the board of directors. The transaction was approved by the board upon the recommendation of a special committee of disinterested directors, ensuring that the terms were evaluated fairly.
This issuance of common stock was conducted in reliance on an exemption from the registration requirements of the Securities Act of 1933, specifically under Section 4(a)(2). This move is expected to have a small positive effect on the stock price as it reflects the company's ongoing financing activities and its ability to convert preferred shares into common equity, which may enhance liquidity and shareholder value in the long run.